Hunting Hill Global Capital’s Meridian Bioscience Inc VIVO Stock Holding History

Hunting Hill Global Capital’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-32,795	Closed	-$1.09M	–	117
2022 Q4	$1.09M	Buy	+32,795	New	+$1.06M	0.71%	17

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Hunting Hill Global Capital's VIVO Position: Q1 2023 in Review

Hunting Hill Global Capital sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 32,795 shares — an estimated $1.09M sold.

Hunting Hill Global Capital first reported a position in VIVO in Q4 2022 and held it in 1 quarter. The position peaked at $1.09M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Hunting Hill Global Capital reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Hunting Hill Global Capital sold 32,795 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.09M.
Hunting Hill Global Capital first reported a position in Meridian Bioscience Inc in Q4 2022 and held it in 1 quarter.
Hunting Hill Global Capital's Meridian Bioscience Inc position peaked at $1.09M in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Hunting Hill Global Capital's 13F filing for Q1 2023, filed 15 May 2023.